Secondary neoplasms following treatment for brain tumors.
Weinstein
Joanna L
JL
Division of Hematology, Oncology and Stem Cell Transplantation, Children's Memorial Hospital, Chicago, IL, USA. jweinstein@childrensmemorial.org
Ayyanar
Kanyalakshmi
K
Watral
Melody A
MA
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D016371:Cranial Irradiation / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006402:Hematologic Diseases / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000453:epidemiology / Q000209:etiology; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D012307:Risk Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology; D017741:Survivors; D013964:Thyroid Neoplasms / Q000453:epidemiology / Q000209:etiology; D013997:Time Factors
D000970:Antineoplastic Agents